New weight-loss scams fueled by GLP-1 hype
GLP-1 medications like Ozempic and Wegovy have surged in popularity, but so have scams targeting people eager to…
New federal agreement lowers GLP-1 drug prices for Westporters
GLP-1 brands – Contributed images By Amy M. Lohman, MD, Bariatric Medicine, Family Medicine, Nuvance Health now part…
Pharma MNCs Won’t Sell Drugs To Doctors Without Valid APC
KUALA LUMPUR, Jan 6 — Multinational drug makers have refused to sell their products to medical practitioners who…
Parliament Report Blames System Failure for PNG Drug Shortages
 Papua New Guinea Prime Minister James Marape has stepped in to address chronic medicine shortages, placing the Health…
People coming off weight-loss injections risk fast weight gain
Michelle RobertsDigital health editor Getty Images Slimmers who come off weight-loss injections such as Mounjaro or Wegovy can…
British study shows how fast kilos return after ending weight-loss drugs
PARIS – When people stop taking the new generation of weight-loss drugs they pile back on the kilos…
Adult shop says FDA sent threat over chest binder sales
PHILADELPHIA (KYW Newsradio) — A popular South Street boutique said it is being singled out by the federal…
AI starts autonomously writing prescription refills in Utah
Caution The first 250 renewals for each drug class will be reviewed by real doctors, but after that,…
NHS warning to people using weight loss injections like Mounjaro
The NHS has issued an important notice to anyone using weight loss injections who also takes the contraceptive…
Milestone announces acceptance of MAA by EMA for etripamil nasal spray
Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
NHS issues warning for Mounjaro users on oral medications |
NHS flags a key heads up for anyone turning to Mounjaro jabs in their weight loss push. The…
U.S. Brand-Name Drug Prices Fell in 2025 as the Net Pricing Drug Channel Emerges
It’s time for Drug Channels’ annual examination of U.S. brand-name drug pricing. For 2025, brand-name drugs’ average list…